Literature DB >> 24293846

Risk factors and clinical aspects of recurrent invasive cervical carcinoma.

Fatemeh Ghaemmaghami1, Sorayya Saleh-Gargari, Behrokh Sahebdel, Nadereh Behtash, Farhad Samiei.   

Abstract

OBJECTIVES: Recurrence of cervical cancer is one of the important and plausible discussions in oncology especially in patients with advanced stages. The purpose of this study was to introduce probability invasive cervical carcinoma recurrence as well as determining characteristics and the prognostic factors of this entity.
METHODS: A retrospective study was designed to identify risk factors and pattern of uterine cervical carcinoma recurrence evaluating the outcome of 36 registered patients. Recurrence was defined based on clinical or para-clinical documentation over at least 6 months after complete remission following surgery or radiotherapy. Treatment consisted of a radiosurgical combination and exclusive radiotherapy.
RESULTS: Mean age in selected patients is 54.8 ± 12.0 years. The pathological reports of primary diagnosis are squamous cell carcinoma in 94.44 % and adenocarcinoma in remaining patients. Mean duration of recurrence among patients is 2.75 ± 1.5 years after the initial treatment. Metrorrhagia is mostly revealing symptom which patients present in recurrent episode. Usually, the recurrence of cervical cancer is presented in pelvic cavity locally. Marginal involvement is documented in 50 % of cases and lymph node in 33.3 % of patients with recurrent episode being involved. Most important prognostic factors are improper treatment (16.66 % of cases) after initial diagnosis.
CONCLUSIONS: Prognostic factors such as selection of appropriate method for treatment are an important point for reducing the rate of recurrence. Moreover, warning patients about symptoms and frequent episodes of follow up is necessary for early diagnosis of recurrence.

Entities:  

Keywords:  Recurrence; Risk factor; Uterine cervix

Year:  2012        PMID: 24293846      PMCID: PMC3575903          DOI: 10.1007/s13224-012-0227-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  15 in total

1.  Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients.

Authors:  M A Mahé; J P Gérard; J B Dubois; A Roussel; E Bussières; M Delannes; F Guillemin; T Schmitt; D Dargent; Y Guillard; P Martel; P Richaud; J C Cuillière; J De Ranieri; L Malissard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-01       Impact factor: 7.038

2.  Retrospective comparison of clinical outcome between radiotherapy alone and surgery plus postoperative radiotherapy in the treatment of stages IB-IIB cervical squamous cell carcinoma.

Authors:  Kiyoshi Ohara; Shinji Sugahara; Kenji Kagei; Masaharu Hata; Hiroshi Igaki; Koichi Tokuuye; Yasuyuki Akine
Journal:  Radiat Med       Date:  2004 Jan-Feb

Review 3.  [Recurrence of uterine cervical cancer more than 5 years after initial therapy].

Authors:  Kazuhiro Takehara; Tsuneo Fujii
Journal:  Nihon Rinsho       Date:  2004-10

4.  Limited value of vaginal cytology in detecting recurrent disease after radical hysterectomy for early stage cervical carcinoma.

Authors:  Napat Injumpa; Prapaporn Suprasert; Jatupol Srisomboon; Kanchana Nimmanahaeminda; Chailert Phongnarisorn; Sitthicha Siriaree; Kittipat Charoenkwan; Chalong Cheewakriangkrai; Chumnan Kietpeerakool
Journal:  Asian Pac J Cancer Prev       Date:  2006 Oct-Dec

5.  Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.

Authors:  M D Logsdon; P J Eifel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

6.  Invasive carcinoma of the uterine cervix in Iran.

Authors:  M Haghdel; M S Ardakany; B Zeighami
Journal:  Int J Gynaecol Obstet       Date:  1999-03       Impact factor: 3.561

7.  The role of clinical follow up in early stage cervical cancer in South Wales.

Authors:  K C K Lim; R E J Howells; A S Evans
Journal:  BJOG       Date:  2004-12       Impact factor: 6.531

8.  Distant metastases after irradiation alone in carcinoma of the uterine cervix.

Authors:  H Fagundes; C A Perez; P W Grigsby; M A Lockett
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

9.  Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.

Authors:  H M Shingleton; S J Soong; M S Gelder; K D Hatch; V V Baker; J M Austin
Journal:  Obstet Gynecol       Date:  1989-06       Impact factor: 7.661

10.  Retreatment of very late recurrent invasive squamous cell carcinoma of the cervix with irradiation. II. Criteria for patients' selection to achieve the success.

Authors:  T Prempree; R Amornmarn; U Villasanta; T Kwon; R M Scott
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

View more
  2 in total

1.  NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.

Authors:  Yue Ma; Jienan Kong; Guanghai Yan; Xiangshan Ren; Dan Jin; Tiefeng Jin; Lijuan Lin; Zhenhua Lin
Journal:  BMC Cancer       Date:  2014-06-09       Impact factor: 4.430

2.  Pattern of Failure with Locally Advanced Cervical Cancer– A Retrospective Audit and Analysis of Contributory Factors

Authors:  Anis Bandyopadhyay; Upasana Mukherjee; Sandip Ghosh; Saurav Ghosh; Shyamal Kumar Sarkar
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.